Mono Pharmacare Stock Screener | Share Price & Fundamental Analysis
MONOPHARMA
Pharmaceuticals
Track Mono Pharmacare share price live with TickJournal's free stock screener.
Browse MONOPHARMA complete financial to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Mono Pharmacare Market Cap
₹22.79 Cr.
MONOPHARMA P/E Ratio (TTM)
-
Mono Pharmacare P/B Ratio
0.71
EPS (TTM)
₹1.75
Dividend Yield
-
Debt to Equity
1.60
MONOPHARMA 52 Week High
-
Mono Pharmacare 52 Week Low
-
Operating Margin
-
Profit Margin
-
MONOPHARMA Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹110.00
Total Equity
₹31.00
Mono Pharmacare Share Price History - Stock Screener Chart
Screen MONOPHARMA historical share price movements with interactive charts. Analyze price trends and patterns.
Mono Pharmacare Company Profile - Fundamental Screener
Screen Mono Pharmacare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MONOPHARMA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0OIP01012
Mono Pharmacare Balance Sheet Screener
Screen MONOPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 110 | 81 | 63 |
| Current Assets | 109 | 80 | 61 |
| Fixed Assets | 1 | 1 | 1 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 26 | 17 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 31 | 28 | 13 |
| Share Capital | 18 | 18 | 12 |
| Reserves & Surplus | 14 | 10 | 1 |
Mono Pharmacare Income Statement Screener - Profit & Revenue Analysis
Screen Mono Pharmacare income statement and profit fundamentals.
Analyze MONOPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Mono Pharmacare share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March |
|---|---|---|---|---|
| Revenue | 0 | 169 | 122 | 27 |
| Expenses | 0 | 161 | 116 | 26 |
| EBITDA | 0 | 9 | 6 | 2 |
| Operating Profit % | 0.00% | 5.00% | 5.00% | 6.00% |
| Depreciation | 0 | 0 | 0 | 0 |
| Interest | 0 | 4 | 3 | 1 |
| Profit Before Tax | 0 | 5 | 3 | 1 |
| Tax | 0 | 1 | 1 | 0 |
| Net Profit | 0 | 3 | 3 | 1 |
| EPS | 0.00 | 1.75 | 1.59 | 0.71 |
Mono Pharmacare Cash Flow Screener - Liquidity Fundamentals
Screen MONOPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | -4 | -9 | -28 |
| Investing Activities | 0 | 0 | -1 |
| Financing Activities | 5 | 8 | 30 |
| Net Cash Flow | 0 | 0 | 0 |
Mono Pharmacare Shareholding Pattern Screener
See Mono Pharmacare shareholding pattern with promoter, FII, and DII holdings.
Check Mono Pharmacare promoter holding and ownership changes for MONOPHARMA on TickJournal.
| Item | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Apr | 2023-Aug | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 56.72% | 56.72% | 56.72% | 56.72% | 81.03% | 81.03% | 56.72% | 56.72% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 35.60% | 34.48% | 36.69% | 35.27% | 0.00% | 0.00% | 38.13% | 37.21% |
| Other Holding | 7.68% | 8.80% | 6.59% | 8.01% | 18.97% | 18.97% | 5.14% | 6.07% |
| Shareholder Count | 478 | 514 | 418 | 463 | 17 | 17 | 972 | 528 |
Mono Pharmacare Share Dividend Screener - Share Yield Analysis
Check Mono Pharmacare dividend history with payout and yield data.
View Mono Pharmacare dividend details including ex-dates and amounts for MONOPHARMA stock.
Mono Pharmacare Stock Index Membership
See which indices include Mono Pharmacare stock.
Check MONOPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Mono Pharmacare Market Events Screener - Corporate Actions
Get Mono Pharmacare corporate actions including splits, bonuses, and buybacks.
Check Mono Pharmacare stock events that may affect MONOPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 8.53% | ||
| 2026-04-30 | 2026-04-30 | Extraordinary General Meeting | NA | 12.11% |
| 2025-11-29 | 2025-11-29 | Quarterly Result Announcement | NA | 10.25% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 11.83% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -2.23% |
Mono Pharmacare Competitors Screener - Peer Comparison
Screen MONOPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 403,112 | 36.57 | 54,729 | 9.71% | 10,980 | 42.76 |
| Divis Laboratories | 169,329 | 67.34 | 9,712 | 18.67% | 2,191 | 64.61 |
| Torrent Pharmaceuticals | 140,360 | 60.79 | 11,539 | 6.99% | 1,911 | 48.05 |
| Dr Reddys Laboratories | 111,091 | 18.39 | 33,741 | 16.73% | 5,725 | 65.07 |
| Lupin | 107,012 | 22.59 | 22,910 | 13.74% | 3,306 | 57.36 |
| Cipla | 105,488 | 22.01 | 28,410 | 7.12% | 5,291 | 64.00 |
| Zydus Life Science | 95,225 | 18.61 | 23,511 | 18.55% | 4,615 | 63.05 |
| Mankind Pharma | 94,652 | 51.17 | 12,744 | 20.90% | 2,007 | 72.17 |
| Aurobindo Pharma | 83,368 | 23.68 | 32,346 | 9.43% | 3,484 | 73.85 |
| Alkem Laboratories | 66,006 | 27.67 | 13,458 | 3.70% | 2,216 | 52.98 |
Mono Pharmacare Company Announcements - News Screener
Screen MONOPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.